Find NINDS Clinical Trials

Returning 32 results
Study Titlesort descending Location Status Disorders
A 48-Week (24-Week Baseline Followed by a 24-Week Treatment) Phase II Pilot Study of the Tolerability and Effect/Efficacy of Subcutaneously Administered Insulin-Like Growth Factor-1 (rhIGF) (CEP-151) in Multiple Sclerosis (MS) Patients Maryland Completed Multiple Sclerosis
A Comparison of an Implanted Neuroprosthesis With Sensory Training for Improving Airway Protection in Chronic Dysphagia Maryland* Completed Chronic Dysphagia, Multiple Sclerosis, Parkinson Disease
Assessment of Patients With Multiple Sclerosis (MS) Maryland* Completed Herpesviridae Infection, HTLV-I Infection, Multiple Sclerosis, Tropical Spastic Paraparesis, Vasculitis
Biomarkers in Multiple Sclerosis Maryland* Completed Multiple Sclerosis
Brain Peripheral Benzodiazepine Receptors in Patients With Multiple Sclerosis Maryland* Completed Multiple Sclerosis
Comprehensive Multimodal Analysis of Neuroimmunological Diseases of the Central Nervous System Maryland* Recruiting Central Nervous System Disease, Multiple Sclerosis
Double Blind Combination of Rituximab by Intravenous and Intrathecal Injection Versus Placebo in Patients With Low-Inflammatory Secondary Progressive Multiple Sclerosis (RIVITaLISe) Maryland* Terminated Multiple Sclerosis
Effect of Corticosteroids on Inflammation at the Edge of Acute Multiple Sclerosis Plaques Canada Enrolling by Invitation Multiple Sclerosis
Effects of Stimulation Patterns of Deep Brain Stimulation Multiple U.S. Locations Enrolling by Invitation Parkinson Disease, Essential Tremor, Multiple Sclerosis
Idebenone for Primary Progressive Multiple Sclerosis Maryland* Enrolling by Invitation Multiple Sclerosis, Primary Progressive Multiple Sclerosis